+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs

Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs

Journal of Enzyme Inhibition and Medicinal Chemistry 31(Sup1): 177-183

The main group of enzymes responsible for the collagen and other protein degradation in extracellular matrix (ECM) are matrix metalloproteinases (MMPs). Collagen is the main structural component of connective tissue and its degradation is a very important process in the development, morphogenesis, tissue remodeling, and repair. Typical structure of MMPs consists of several distinct domains. MMP family can be divided into six groups: collagenases, gelatinases, stromelysins, matrilysins, membrane-type MMPs, and other non-classified MMPs. MMPs and their inhibitors have multiple biological functions in all stages of cancer development: from initiation to outgrowth of clinically relevant metastases and likewise in apoptosis and angiogenesis. MMPs and their inhibitors are extensively examined as potential anticancer drugs. MMP inhibitors can be divided into two main groups: synthetic and natural inhibitors. Selected synthetic inhibitors are in clinical trials on humans, e.g. synthetic peptides, non-peptidic molecules, chemically modified tetracyclines, and bisphosphonates. Natural MMP inhibitors are mainly isoflavonoids and shark cartilage.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 058275465

Download citation: RISBibTeXText

PMID: 27028474

DOI: 10.3109/14756366.2016.1161620

Related references

Extracellular matrix metalloproteinase inducer (EMMPRIN) remodels the extracellular matrix through enhancing matrix metalloproteinases (MMPs) and inhibiting tissue inhibitors of MMPs expression in HPV-positive cervical cancer cells. European Journal of Gynaecological Oncology 36(5): 539-545, 2015

Expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) in experimental systems of cartilage matrix degradation. International Journal of Experimental Pathology 81(1): A12-A13, 2008

Proteolytic Events of Wound-Healing -- Coordinated Interactions Among Matrix Metalloproteinases (MMPs), Integrins, and Extracellular Matrix Molecules. Critical Reviews in Oral Biology & Medicine 12(5): 373-398, 2001

Proteolytic events of wound-healing--coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules. Critical Reviews in Oral Biology and Medicine 12(5): 373-398, 2002

Alcohol modulation of cardiac matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs favors collagen accumulation. Alcoholism, Clinical and Experimental Research 38(2): 448-456, 2014

Extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinases (MMPs) as regulators of tumor-host interaction in a spontaneous metastasis model in rats. Histochemistry and Cell Biology 130(6): 1155-1164, 2008

Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma. Journal of Pathology 182(3): 347-355, 1997

Sequestration of matrix metalloproteinases -1, -3 and -8 by the alpha2-chain of collagen VI in the extracellular matrix. Naunyn-Schmiedeberg's Archives of Pharmacology 362(4-5 Suppl.): R19, 2000

Matrix metalloproteinases -1, -3 and -8 are exclusively bound by the alpha2-chain of collagen VI in the liver extracellular matrix. Journal of Hepatology 32(Suppl. 2): 64, 2000

Collaborative interactions between neutrophil elastase and metalloproteinases in extracellular matrix degradation in three-dimensional collagen gels. Respiratory Research 2(5): 300-305, 2001

mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic leukemia: potential role of TIMP1 as an adverse prognostic factor. Leukemia Research 34(1): 32-37, 2010

A role for extracellular matrix degradation and matrix metalloproteinases in senile dementia?. Acta Neuropathologica. 87(3): 308-312, 1994

Matrix metalloproteinases produced by IL-2 activated natural killer cells and extracellular matrix degradation. Natural Immunity 15(4): 187, 1996-, 1997

Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in aortic dissection. Human Pathology 31(6): 640-646, 2000

Degradation of extracellular matrix by matrix metalloproteinases and joint destruction. Seikagaku. Journal of Japanese Biochemical Society 73(11): 1309-1321, 2002